Form 4: CoreWeave CDO Sells Shares via Pre-Planned Trust Sales

CoreWeave's Chief Development Officer, Brannin McBee, executed pre-planned sales of Class A Common Stock totaling 22,915 shares through grantor retained annuity trusts.

Summary

• Brannin McBee, CoreWeave's Chief Development Officer, reported transactions involving Class A Common Stock.
• Transactions included the acquisition of 16,665 shares and 6,250 shares of Class A Common Stock through conversion from Class B Common Stock, held indirectly by the Canis Major 2025 GRAT and Canis Minor 2025 GRAT, respectively.
• Simultaneously, 16,665 shares of Class A Common Stock were disposed of from the Canis Major 2025 GRAT and 6,250 shares from the Canis Minor 2025 GRAT.
• These sales were executed on March 30, 2026, pursuant to a Rule 10b5-1 trading plan adopted on November 17, 2025.
• The sales occurred at weighted average prices ranging from $67.6696 to $75.19 per share.
• Following these transactions, McBee continues to hold significant indirect beneficial ownership through various trusts and LLCs, including 54,000 Class A Common Stock shares via Canis Major SM Trust and 1,800 shares via a child's direct holding.
• Derivative holdings include 4,017,237 Class B Common Stock shares via Canis Major 2025 GRAT, 598,705 via Canis Minor 2025 GRAT, and substantial holdings through other family trusts and LLCs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transactions are routine insider sales executed under a pre-planned 10b5-1 program, which typically does not signal a change in management's outlook on the company's prospects.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned sales rather than a reaction to immediate company performance or market conditions.
• The reporting person maintains significant beneficial ownership in CoreWeave through various trusts and direct holdings, demonstrating continued alignment with shareholder interests.

Negatives

• The sale of 22,915 shares of Class A Common Stock by a Chief Development Officer, even if pre-planned, could be perceived by some investors as a reduction in direct exposure to the company's equity.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding CoreWeave's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are a routine part of executive compensation and wealth management strategies. While sales can sometimes signal a lack of confidence, pre-planned sales typically mitigate this concern, suggesting a structured approach to liquidity rather than a reaction to specific company news. In the high-growth technology sector, executives often diversify their holdings over time.

Comparison to Industry Standards

• Insider selling through 10b5-1 plans is a common practice among executives in publicly traded companies across various industries, including technology and finance, for personal financial planning and diversification.
• Compared to peers like NVIDIA or AMD, whose executives also frequently utilize 10b5-1 plans for stock sales, these transactions by CoreWeave's CDO align with standard corporate governance practices for managing executive equity holdings.
• The volume of shares sold (22,915 shares) represents a relatively small portion of the reporting person's total beneficial ownership, which includes millions of Class B Common Stock shares convertible to Class A, suggesting a measured approach to liquidity rather than a significant divestment.

Related Party Transactions

• The transactions involve grantor retained annuity trusts (GRATs) where the reporting person is the sole trustee and beneficiary (Canis Major 2025 GRAT, Canis Major 2026 GRAT).
• Another GRAT (Canis Minor 2025 GRAT, Canis Minor 2026 GRAT) involves the reporting person's spouse as the sole beneficiary and trustee.
• Beneficial ownership is also held through the Canis Major SM Trust, an irrevocable trust for the reporting person's minor child, where the reporting person has the power to remove and replace the trustee.
• Additional indirect holdings are through LLCs (Canis Major 2024 Irrevocable Trust LLC, Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC) where the reporting person serves as manager.

Stakeholder Impact

• Shareholders: May interpret the sales as a routine diversification strategy by an executive, especially given the 10b5-1 plan. However, some may view any insider selling, even pre-planned, with caution.
• Management/Employees: No direct impact on day-to-day operations or employment.

Key Dates

Recommendation

The filing details routine insider stock sales executed under a pre-established 10b5-1 trading plan. Such transactions are typically for personal financial planning and diversification, rather than a reflection of new material information about the company's performance or outlook. Therefore, it does not provide a strong signal for a 'buy' or 'sell' recommendation, warranting a 'hold' position for investors awaiting more substantive company updates.

Keywords

CoreWeave, CRWV, Insider Trading, Form 4, Brannin McBee, Chief Development Officer, Stock Sale, 10b5-1 Plan, Class A Common Stock, Class B Common Stock, Grantor Retained Annuity Trust, GRAT